Neogenix Oncology, Inc. (Neogenix), located in the Shady Grove Innovation Center is back in the spotlight for being named Emerging Company of the Year by the Tech Council of Maryland (TCM) during their 2010 Tech Awards held May 13! The Tech Awards recognize individuals and organizations for innovation, dedication and outstanding service to Maryland’s technology community. Johns Hopkins Hospital recently initiated a Phase I trial of Neogenix’s first therapeutic antibody, NPC-1C, in patients with late stage pancreatic or colorectal cancer.
Montgomery County Innovation Network
